Suchergebnisse - "Han, Hyo S"

PubPharm (74)

1

Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer : results from the dose expansion groups of an open-label, phase 1b study

enthalten in: The Lancet. Oncology | 2024

von Layman, R. | Han, H. | Rugo, H. | +9

2

Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development

enthalten in: Molecular aspects of medicine | 2024

von Gautam, N. | Ramamoorthi, G. | Champion, N. | +2

3

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3) : Final overall survival results from a randomized phase 3 trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Diéras, V. | Han, H. | Wildiers, H. | +8

4

Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer

enthalten in: JAMA network open | 2023

von Kyalwazi, B. | Yau, C. | Campbell, M. | +31

5

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases

enthalten in: Journal of neuro-oncology | 2023

von Khatri, V. | Mills, M. | Oliver, D. | +6

6

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases

enthalten in: Journal of neuro-oncology | 2023

von Khatri, V. | Mills, M. | Oliver, D. | +6

7

Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases

enthalten in: Journal of neuro-oncology | 2023

von Khatri, V. | Mills, M. | Oliver, D. | +6

8

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression

enthalten in: JCO precision oncology | 2023

von Brett, J. | Dubash, T. | Johnson, G. | +29

9

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer : the I-SPY SURMOUNT study

enthalten in: Breast cancer research and treatment | 2023

von Magbanua, M. | van 't Veer, L. | Clark, A. | +24

10

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study

enthalten in: Breast cancer research and treatment | 2023

von Magbanua, M. | van ‘t Veer, L. | Clark, A. | +24

1
2
3
4
5
6
7
8
Nächster »
[8]